Literature DB >> 9778216

Imbalance between interstitial collagenase and tissue inhibitor of metalloproteinases 1 in synoviocytes and fibroblasts upon direct contact with stimulated T lymphocytes: involvement of membrane-associated cytokines.

D Burger1, R Rezzonico, J M Li, C Modoux, R A Pierce, H G Welgus, J M Dayer.   

Abstract

OBJECTIVE: To determine whether direct cell-cell contact with stimulated T lymphocytes (a) differentially modulates the production of interstitial collagenase (matrix metalloproteinase 1 [MMP-1]) and tissue inhibitor of metalloproteinases 1 (TIMP-1) on human synoviocytes and dermal fibroblasts, and (b) induces the production of prostaglandin E2 (PGE2); and to identify the membrane-associated factors on T cell surfaces involved in these mechanisms.
METHODS: Dermal fibroblasts and fibroblast-like synovial cells (synoviocytes) were cultured with fixed T cells, isolated plasma membranes from T cells, interleukin-1beta (IL-1beta; 250 pg/ml), or transforming growth factor beta (TGFbeta; 5 ng/ml). Culture supernatants were assayed for the production of MMP-1, TIMP-1, and PGE2. The expression of MMP-1 and TIMP-1 messenger RNA was analyzed by Northern blot of total fibroblast RNA.
RESULTS: Membranes of stimulated T cells, i.e., human peripheral blood T lymphocytes (PBTL) and the human T cell line HUT-78, induced the production of PGE2 and MMP-1 on both synoviocytes and dermal fibroblasts. TIMP-1 production was enhanced upon contact with PBTL stimulated for short periods of time (2-4 hours) but not for longer periods. Similar results were obtained with CD4+ and CD8+ synovial tissue T cell clones (TCCs), which induced the production of TIMP-1 by fibroblasts when stimulated for short (2-4 hours), but not long, periods of time. This time dependency was not observed with HUT-78 cells. The production of MMP-1 by fibroblasts and synoviocytes upon cellular contact with stimulated T cells was higher than that induced by an optimum concentration of IL-1beta, whereas the production of PGE2 was equivalent or slightly lower. Cell membrane-associated IL-1alpha and tumor necrosis factor a, but not CD69, CD40 ligand, or CD11b, were involved in the induction of MMP-1 and PGE2 production, as shown by blockade experiments using monoclonal antibodies and cytokine antagonists.
CONCLUSION: Synovial tissue TCCs and PBTL stimulated for long periods of time trigger the production of PGE2 and MMP-1, but not TIMP-1, in synoviocytes and dermal fibroblasts, thus inducing an imbalance between the metalloenzyme and its inhibitor. These results demonstrate that T cells may affect fibroblast and synoviocyte functions directly (i.e., by contact activation) and indirectly (i.e., by activation of cytokine production in monocyte/macrophages, which in turn, trigger stromal cell functions). Since the production of MMPs in monocyte/macrophages is also induced upon contact with stimulated T cells, our results strongly suggest that contact of synovial cells with chronically stimulated T lymphocytes favors matrix catabolism. By analogy, this mechanism may trigger tissue destruction in vivo and, thus, may potentiate tissue destruction in chronic inflammatory diseases such as RA.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9778216     DOI: 10.1002/1529-0131(199810)41:10<1748::AID-ART7>3.0.CO;2-3

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  31 in total

Review 1.  Interleukin-18, rheumatoid arthritis, and tissue destruction.

Authors:  J M Dayer
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

Review 2.  T lymphocyte and fibroblast interactions: the case of skin involvement in systemic sclerosis and other examples.

Authors:  C Chizzolini
Journal:  Springer Semin Immunopathol       Date:  1999

Review 3.  New therapies in development for autoimmune diseases: their rationale for combination treatment.

Authors:  V Strand
Journal:  Springer Semin Immunopathol       Date:  2001

4.  Blockade of T cell contact-activation of human monocytes by high-density lipoproteins reveals a new pattern of cytokine and inflammatory genes.

Authors:  Lyssia Gruaz; Céline Delucinge-Vivier; Patrick Descombes; Jean-Michel Dayer; Danielle Burger
Journal:  PLoS One       Date:  2010-02-25       Impact factor: 3.240

5.  Porphyromonas gingivalis gingipain-R enhances interleukin-8 but decreases gamma interferon-inducible protein 10 production by human gingival fibroblasts in response to T-cell contact.

Authors:  M Oido-Mori; R Rezzonico; P L Wang; Y Kowashi; J M Dayer; P C Baehni; C Chizzolini
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

Review 6.  Role of tumour necrosis factor alpha in experimental arthritis: separate activity of interleukin 1beta in chronicity and cartilage destruction.

Authors:  W B van den Berg; L A Joosten; G Kollias; F A van De Loo
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

Review 7.  Scientific basis of botanical medicine as alternative remedies for rheumatoid arthritis.

Authors:  Cindy L H Yang; Terry C T Or; Marco H K Ho; Allan S Y Lau
Journal:  Clin Rev Allergy Immunol       Date:  2013-06       Impact factor: 8.667

8.  Insulin-like growth factor-binding protein-5 induces pulmonary fibrosis and triggers mononuclear cellular infiltration.

Authors:  Hidekata Yasuoka; Zhihong Zhou; Joseph M Pilewski; Tim D Oury; Augustine M K Choi; Carol A Feghali-Bostwick
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

9.  Molecular interactions between T cells and fibroblast-like synoviocytes: role of membrane tumor necrosis factor-alpha on cytokine-activated T cells.

Authors:  Chinh N Tran; Steven K Lundy; Peter T White; Judith L Endres; Christopher D Motyl; Raj Gupta; Cailin M Wilke; Eric A Shelden; Kevin C Chung; Andrew G Urquhart; David A Fox
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

10.  Proteolytic cleavage of type I collagen generates an autoantigen in autoimmune uveitis.

Authors:  Purushottam Jha; Balasubramanian Manickam; Bharati Matta; Puran S Bora; Nalini S Bora
Journal:  J Biol Chem       Date:  2009-09-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.